Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001

Polycythemia vera (PV) is a chronic myeloproliferative neoplasm (MPN) characterized by excessive production of red blood cells. Patients with PV are at a risk of thrombosis, bleeding, and transformation to myelofibrosis or acute myeloid leukemia. Therapy for PV is based on the use of phlebotomy, asp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Hematol
Päätekijät: Nussenzveig, Roberto H., Cortes, Jorge, Sever, Matjaz, Quintás-Cardama, Alfonso, Ault, Pat, Manshouri, Taghi, Bueso-Ramos, Carlos, Prchal, Josef T., Kantarjian, Hagop, Verstovsek, Srdan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378576/
https://ncbi.nlm.nih.gov/pubmed/19484334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-009-0345-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia